Anne Li Feburary 2nd, 2018
A drug for certain types of breast cancer has been approved for the NHS in England. The National Institute for Health and Care Excellence (NICE) issued its final decision, recommending pertuzumab (Perjeta) for some women with breast cancer. The drug previously had to be accessedthrough the Cancer Drugs Fund. NICE has recommended the drug for women who have HER2-positive breast cancer. The decision covers those patients whose breast cancer has returned to the breast but can’t be treated with surgery, or where it has spread to other parts of the body, and is given in combination with other treatment.
See original article at: http://www.cancerresearchuk.org/about-us/cancer-news/news-report/2018-02-02-breast-cancer-drug-approved-for-nhs-in-england